Nef-specific CD45RA+ CD8+ T cells secreting MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection
Claudia J. Dembek(Helmholtz Munich), Antonio Cosma(Luxembourg Institute of Health), Thomas Vollbrecht(University of California San Diego), Sarah Kutscher(Helmholtz Munich), Guido Poli(University of Verona), Simone Allgayer(Helmholtz Munich), Johannes R. Bogner(Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation), Rika Draenert(Harvard University), Volker Erfle, Priscilla Biswas(Mario Negri Institute for Pharmacological Research), Dieter Hoffmann(Technical University of Munich), Mauro Malnati(Vita-Salute San Raffaele University), Paolo Lusso(National Institute of Allergy and Infectious Diseases), Elisa Vicenzi(Mario Negri Institute for Pharmacological Research), Silvia Heltai(IRCCS Ospedale San Raffaele), Giuseppe Tambussi(San Raffaele University of Rome), Peter Reitmeir(Institute of Groundwater Ecology), Ulrike Protzer(German Center for Infection Research), Elena Santagostino(University of Milan), F. D. Goebel(LMU Klinikum), Silvia Ghezzi(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), H J Stellbrink(Infektionsmedizinisches Centrum Hamburg), Marco Tinelli(Ospedale Maggiore di Lodi)
Cited by 9
Related Papers
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635